Opthea Limited

NasdaqGS OPT

Opthea Limited EBITDA Margin for the year ending June 30, 2024: -160,443.72%

Opthea Limited EBITDA Margin is -160,443.72% for the year ending June 30, 2024, a -15.80% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Opthea Limited EBITDA Margin for the year ending June 30, 2023 was -138,554.61%, a -30.11% change year over year.
Opthea Limited EBITDA Margin for the year ending June 30, 2022 was -106,489.56%, a -85.34% change year over year.
Opthea Limited EBITDA Margin for the year ending June 30, 2021 was -57,455.77%, a -100.06% change year over year.
Opthea Limited EBITDA Margin for the year ending June 30, 2020 was -28,718.63%, a -22.52% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NasdaqGS: OPT

Opthea Limited

CEO	Dr. Frederic Guerard M.S., Pharm.D.
IPO Date	Oct. 16, 2020
Location	Australia
Headquarters	650 Chapel Street
Employees	33
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Key trends

Past 5 years